Global CDMO footprint TriRx operates across the United States and Europe with state-of-the-art facilities, presenting a compelling opportunity to offer multi-region development, manufacturing, and packaging services to clients seeking global supply chain resilience and regulatory alignment.

Animal Health Growth With capabilities spanning animal health products alongside human pharma, TriRx can target biotech startups and pharma companies expanding animal health portfolios, offering integrated development, fill/finish, and aseptic compounding.

Expansion Momentum Recent facility investments and acquisitions (Speke facility, Elanco asset integration, and upstream monoclonal antibody capabilities) indicate a growth trajectory and capacity expansion that can be leveraged to upsell scale-up manufacturing, tech transfer, and new modality production.

Quality & Compliance TriRx emphasizes FDA and EMA regulatory adherence with rigorous quality control, appealing to risk-averse clients needing compliant CMO partnerships for sterile, non-sterile, and biologics programs across clinical to commercial stages.

Leadership & Access Executive hires in sales and direct access to teams, plus the promise of client-centric collaboration (your product, your facility, your team) positions TriRx as a trusted partner for startups and midsize players seeking transparent, responsive CDMO support.